 Kentaro Yomogida
Concepts (418)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription Factors | 14 | 2023 | 1567 | 1.460 |
Why?
| | Muscles | 2 | 2024 | 332 | 1.040 |
Why?
| | Testis | 27 | 2008 | 144 | 1.030 |
Why?
| | Spermatogenesis | 17 | 2013 | 53 | 0.960 |
Why?
| | Ice | 1 | 2024 | 22 | 0.950 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2023 | 12 | 0.940 |
Why?
| | T-Box Domain Proteins | 2 | 2021 | 96 | 0.830 |
Why?
| | Lymphocyte Subsets | 1 | 2021 | 76 | 0.810 |
Why?
| | Sertoli Cells | 7 | 2004 | 25 | 0.740 |
Why?
| | Perciformes | 1 | 2020 | 17 | 0.730 |
Why?
| | Immunity, Cellular | 1 | 2021 | 268 | 0.710 |
Why?
| | Cryopreservation | 1 | 2020 | 99 | 0.690 |
Why?
| | Immunity, Innate | 2 | 2021 | 744 | 0.660 |
Why?
| | Interleukin-17 | 2 | 2014 | 105 | 0.550 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2013 | 70 | 0.520 |
Why?
| | Mice | 46 | 2024 | 15425 | 0.500 |
Why?
| | DNA-Binding Proteins | 12 | 2008 | 1343 | 0.480 |
Why?
| | Superantigens | 1 | 2013 | 68 | 0.450 |
Why?
| | Th1 Cells | 1 | 2013 | 132 | 0.430 |
Why?
| | Magnetic Fields | 2 | 2024 | 22 | 0.420 |
Why?
| | Cell Polarity | 1 | 2013 | 133 | 0.420 |
Why?
| | Streptavidin | 1 | 2012 | 17 | 0.420 |
Why?
| | Freezing | 2 | 2024 | 86 | 0.410 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 181 | 0.410 |
Why?
| | Arthritis, Experimental | 1 | 2013 | 133 | 0.400 |
Why?
| | Animals | 51 | 2024 | 33107 | 0.390 |
Why?
| | Interferon-gamma | 3 | 2021 | 735 | 0.380 |
Why?
| | Interleukin-2 | 1 | 2012 | 416 | 0.380 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 356 | 0.360 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1063 | 0.310 |
Why?
| | Intestinal Mucosa | 2 | 2023 | 527 | 0.290 |
Why?
| | Spermatogonia | 7 | 2008 | 11 | 0.280 |
Why?
| | Nerve Growth Factors | 2 | 2003 | 74 | 0.270 |
Why?
| | Germ Cells | 7 | 2004 | 64 | 0.270 |
Why?
| | Mice, Inbred C57BL | 18 | 2023 | 4886 | 0.270 |
Why?
| | Gene Expression Regulation | 8 | 2021 | 2433 | 0.250 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1771 | 0.240 |
Why?
| | CD8 Antigens | 1 | 2023 | 70 | 0.230 |
Why?
| | Crystallization | 1 | 2024 | 143 | 0.230 |
Why?
| | Interleukin-15 | 1 | 2023 | 77 | 0.230 |
Why?
| | Mice, Knockout | 7 | 2023 | 2665 | 0.220 |
Why?
| | RNA, Messenger | 20 | 2011 | 2656 | 0.220 |
Why?
| | Base Sequence | 22 | 2006 | 2140 | 0.220 |
Why?
| | Haploidy | 8 | 2003 | 21 | 0.220 |
Why?
| | Membrane Proteins | 3 | 2021 | 1047 | 0.220 |
Why?
| | Zinc Fingers | 4 | 2000 | 46 | 0.210 |
Why?
| | Spermatozoa | 7 | 2006 | 91 | 0.210 |
Why?
| | Neuroglia | 1 | 2003 | 155 | 0.210 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 36 | 0.210 |
Why?
| | RNA, Small Cytoplasmic | 1 | 2021 | 7 | 0.210 |
Why?
| | Granzymes | 1 | 2021 | 40 | 0.200 |
Why?
| | Cell Nucleus | 7 | 2005 | 577 | 0.200 |
Why?
| | Spermatids | 7 | 2013 | 18 | 0.200 |
Why?
| | Liver | 3 | 2021 | 1802 | 0.180 |
Why?
| | Receptors, Cell Surface | 1 | 2022 | 362 | 0.180 |
Why?
| | Molecular Sequence Data | 20 | 2005 | 2844 | 0.180 |
Why?
| | Gene Deletion | 1 | 2021 | 359 | 0.180 |
Why?
| | Eosinophils | 1 | 2022 | 284 | 0.180 |
Why?
| | Transcription, Genetic | 13 | 2008 | 1323 | 0.180 |
Why?
| | DNA, Complementary | 8 | 2005 | 265 | 0.180 |
Why?
| | Palatine Tonsil | 1 | 2019 | 32 | 0.170 |
Why?
| | Antigens, CD | 1 | 2021 | 456 | 0.170 |
Why?
| | Cell Differentiation | 12 | 2019 | 1744 | 0.170 |
Why?
| | Myxoma | 1 | 2018 | 11 | 0.170 |
Why?
| | Gene Expression | 6 | 2003 | 1480 | 0.170 |
Why?
| | Heart Neoplasms | 1 | 2018 | 49 | 0.160 |
Why?
| | Heart Atria | 1 | 2018 | 112 | 0.160 |
Why?
| | Cell Line | 9 | 2014 | 2688 | 0.150 |
Why?
| | Transfection | 8 | 2014 | 886 | 0.150 |
Why?
| | 5-Aminolevulinate Synthetase | 2 | 1997 | 2 | 0.150 |
Why?
| | Lymphocytes | 1 | 2019 | 345 | 0.150 |
Why?
| | Interleukins | 1 | 2019 | 242 | 0.150 |
Why?
| | Mice, Mutant Strains | 3 | 2003 | 279 | 0.140 |
Why?
| | Amino Acid Sequence | 15 | 2005 | 2053 | 0.140 |
Why?
| | Stem Cells | 4 | 2002 | 555 | 0.140 |
Why?
| | Proto-Oncogene Proteins | 3 | 2008 | 615 | 0.130 |
Why?
| | Cloning, Molecular | 9 | 2005 | 536 | 0.130 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2006 | 144 | 0.130 |
Why?
| | Blotting, Northern | 11 | 2003 | 194 | 0.130 |
Why?
| | Green Fluorescent Proteins | 8 | 2005 | 393 | 0.130 |
Why?
| | Cell Proliferation | 2 | 2013 | 2254 | 0.130 |
Why?
| | Immunohistochemistry | 10 | 2013 | 1675 | 0.130 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2014 | 11 | 0.130 |
Why?
| | Male | 43 | 2013 | 57376 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 4 | 2013 | 649 | 0.120 |
Why?
| | Proteins | 4 | 2005 | 936 | 0.120 |
Why?
| | Th17 Cells | 1 | 2014 | 57 | 0.120 |
Why?
| | CD4 Antigens | 1 | 2014 | 126 | 0.120 |
Why?
| | Exons | 9 | 2011 | 305 | 0.120 |
Why?
| | Cell Division | 5 | 2003 | 770 | 0.120 |
Why?
| | Acrosome | 1 | 2013 | 4 | 0.120 |
Why?
| | Monomeric Clathrin Assembly Proteins | 1 | 2013 | 4 | 0.120 |
Why?
| | trans-Golgi Network | 1 | 2013 | 11 | 0.120 |
Why?
| | Biomarkers | 3 | 2021 | 3564 | 0.120 |
Why?
| | Zymosan | 1 | 2013 | 65 | 0.110 |
Why?
| | Carbolines | 1 | 2013 | 29 | 0.110 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2013 | 36 | 0.110 |
Why?
| | Protein Transport | 2 | 2013 | 407 | 0.110 |
Why?
| | Culture Media | 1 | 2013 | 161 | 0.110 |
Why?
| | Cell Membrane Permeability | 1 | 2013 | 86 | 0.110 |
Why?
| | Genes, Bacterial | 1 | 1993 | 159 | 0.110 |
Why?
| | Luminescent Proteins | 6 | 2003 | 173 | 0.110 |
Why?
| | Quality Improvement | 1 | 2020 | 962 | 0.110 |
Why?
| | Microcirculation | 1 | 2013 | 152 | 0.110 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 562 | 0.100 |
Why?
| | Promoter Regions, Genetic | 7 | 2011 | 1151 | 0.100 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2013 | 311 | 0.100 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 353 | 0.100 |
Why?
| | Nuclear Proteins | 3 | 2003 | 591 | 0.100 |
Why?
| | Seminiferous Tubules | 5 | 2008 | 10 | 0.100 |
Why?
| | Spleen | 1 | 2013 | 503 | 0.100 |
Why?
| | Meiosis | 2 | 2003 | 61 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 333 | 0.100 |
Why?
| | Histones | 3 | 2006 | 546 | 0.090 |
Why?
| | Gene Library | 8 | 2003 | 125 | 0.090 |
Why?
| | Lymph Nodes | 1 | 2013 | 443 | 0.090 |
Why?
| | In Situ Hybridization | 8 | 2004 | 303 | 0.090 |
Why?
| | Heat-Shock Proteins | 3 | 2006 | 127 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2013 | 497 | 0.090 |
Why?
| | Infertility, Male | 3 | 2013 | 61 | 0.090 |
Why?
| | Estrogen Receptor alpha | 1 | 2011 | 122 | 0.090 |
Why?
| | Burns | 1 | 2013 | 247 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2008 | 810 | 0.090 |
Why?
| | Autophagy | 1 | 2013 | 312 | 0.090 |
Why?
| | Cell Membrane | 1 | 2013 | 694 | 0.090 |
Why?
| | Testicular Neoplasms | 2 | 2003 | 95 | 0.090 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2006 | 40 | 0.080 |
Why?
| | Genes, Reporter | 6 | 2013 | 268 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 979 | 0.080 |
Why?
| | Flow Cytometry | 1 | 2012 | 1071 | 0.080 |
Why?
| | Humans | 23 | 2019 | 118066 | 0.080 |
Why?
| | Cytoplasm | 3 | 2005 | 269 | 0.080 |
Why?
| | Protein Biosynthesis | 5 | 2003 | 393 | 0.080 |
Why?
| | Blotting, Western | 6 | 2013 | 1185 | 0.080 |
Why?
| | Alternative Splicing | 3 | 2011 | 190 | 0.080 |
Why?
| | Peptides | 1 | 2013 | 873 | 0.080 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2008 | 127 | 0.080 |
Why?
| | Cells, Cultured | 4 | 2019 | 4042 | 0.070 |
Why?
| | Endoplasmic Reticulum | 2 | 2006 | 240 | 0.070 |
Why?
| | Mouth Neoplasms | 1 | 2008 | 79 | 0.070 |
Why?
| | Response Elements | 2 | 2005 | 82 | 0.070 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 2 | 2003 | 17 | 0.070 |
Why?
| | Cyclic AMP Response Element Modulator | 1 | 2006 | 2 | 0.070 |
Why?
| | Receptors, Androgen | 2 | 2005 | 132 | 0.070 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2006 | 93 | 0.070 |
Why?
| | Sperm Tail | 2 | 2002 | 6 | 0.070 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2005 | 6 | 0.070 |
Why?
| | Glycoside Hydrolases | 1 | 2005 | 30 | 0.070 |
Why?
| | Recombinant Proteins | 3 | 2005 | 1301 | 0.070 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 4 | 2003 | 18 | 0.060 |
Why?
| | Gene Targeting | 3 | 2013 | 80 | 0.060 |
Why?
| | GATA1 Transcription Factor | 4 | 2003 | 13 | 0.060 |
Why?
| | Mice, Transgenic | 7 | 2005 | 2011 | 0.060 |
Why?
| | Genes | 2 | 2003 | 224 | 0.060 |
Why?
| | Multigene Family | 1 | 2005 | 199 | 0.060 |
Why?
| | GATA4 Transcription Factor | 1 | 2004 | 18 | 0.060 |
Why?
| | Follicle Stimulating Hormone | 2 | 2002 | 216 | 0.060 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 111 | 0.060 |
Why?
| | Olfactory Receptor Neurons | 1 | 2004 | 67 | 0.060 |
Why?
| | Mitochondrial ADP, ATP Translocases | 1 | 2003 | 1 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1515 | 0.060 |
Why?
| | Female | 14 | 2018 | 61147 | 0.060 |
Why?
| | Electroporation | 1 | 2003 | 33 | 0.060 |
Why?
| | Stem Cell Factor | 2 | 2000 | 14 | 0.060 |
Why?
| | DNA Damage | 1 | 2005 | 356 | 0.060 |
Why?
| | Up-Regulation | 2 | 2004 | 861 | 0.050 |
Why?
| | Phylogeny | 3 | 2005 | 817 | 0.050 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2003 | 57 | 0.050 |
Why?
| | Genetic Engineering | 1 | 2003 | 82 | 0.050 |
Why?
| | Procollagen | 1 | 2002 | 21 | 0.050 |
Why?
| | HeLa Cells | 4 | 2006 | 583 | 0.050 |
Why?
| | Chromosome Mapping | 4 | 2011 | 503 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1159 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 610 | 0.050 |
Why?
| | Prostatic Intraepithelial Neoplasia | 1 | 2002 | 12 | 0.050 |
Why?
| | Spermatocytes | 2 | 2005 | 6 | 0.050 |
Why?
| | Teratoma | 1 | 2003 | 92 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 978 | 0.050 |
Why?
| | RNA-Binding Proteins | 1 | 2005 | 369 | 0.050 |
Why?
| | Molecular Chaperones | 2 | 2006 | 173 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2022 | 304 | 0.050 |
Why?
| | Tissue Distribution | 4 | 2004 | 332 | 0.050 |
Why?
| | Immunomodulation | 1 | 2022 | 89 | 0.050 |
Why?
| | DNA | 5 | 2013 | 1381 | 0.050 |
Why?
| | Intestine, Small | 1 | 2022 | 130 | 0.050 |
Why?
| | Leydig Cells | 2 | 1998 | 12 | 0.050 |
Why?
| | Coenzyme A-Transferases | 1 | 2000 | 1 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2005 | 1588 | 0.050 |
Why?
| | Tumor Suppressor Proteins | 1 | 2003 | 287 | 0.050 |
Why?
| | Ovary | 1 | 2002 | 205 | 0.050 |
Why?
| | Actins | 1 | 2003 | 399 | 0.050 |
Why?
| | Androgen-Binding Protein | 1 | 2000 | 2 | 0.050 |
Why?
| | Ligands | 1 | 2022 | 565 | 0.050 |
Why?
| | Rats | 7 | 1999 | 5329 | 0.050 |
Why?
| | Eosinophilia | 1 | 2022 | 185 | 0.050 |
Why?
| | Collagen | 1 | 2002 | 432 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2000 | 64 | 0.040 |
Why?
| | Testicular Hormones | 1 | 1999 | 9 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-ets | 3 | 2008 | 51 | 0.040 |
Why?
| | Ikaros Transcription Factor | 1 | 2019 | 17 | 0.040 |
Why?
| | Protein Isoforms | 3 | 2011 | 345 | 0.040 |
Why?
| | Binding Sites | 4 | 2006 | 1217 | 0.040 |
Why?
| | Chromatin | 1 | 2003 | 439 | 0.040 |
Why?
| | Purpura | 1 | 2018 | 12 | 0.040 |
Why?
| | Prostate | 1 | 2000 | 158 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 4 | 2000 | 366 | 0.040 |
Why?
| | Sequence Analysis, DNA | 4 | 2005 | 745 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 78 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2002 | 547 | 0.040 |
Why?
| | Exanthema | 1 | 2018 | 77 | 0.040 |
Why?
| | Luciferases | 3 | 2005 | 142 | 0.040 |
Why?
| | Food Hypersensitivity | 1 | 2022 | 260 | 0.040 |
Why?
| | Testosterone | 1 | 2001 | 350 | 0.040 |
Why?
| | Anemia, Sideroblastic | 1 | 1997 | 3 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 1999 | 171 | 0.040 |
Why?
| | Transferrin | 1 | 1997 | 39 | 0.040 |
Why?
| | Cell Lineage | 1 | 1999 | 317 | 0.040 |
Why?
| | X Chromosome | 1 | 1997 | 47 | 0.040 |
Why?
| | Pyridoxine | 1 | 1997 | 26 | 0.040 |
Why?
| | Endopeptidases | 1 | 1997 | 71 | 0.040 |
Why?
| | Erythropoiesis | 1 | 1997 | 33 | 0.040 |
Why?
| | Fever | 1 | 2018 | 283 | 0.040 |
Why?
| | Recombination, Genetic | 1 | 1998 | 173 | 0.040 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1997 | 80 | 0.040 |
Why?
| | Fatigue | 1 | 2018 | 293 | 0.040 |
Why?
| | Nucleic Acid Hybridization | 2 | 1997 | 192 | 0.040 |
Why?
| | Introns | 4 | 1999 | 230 | 0.040 |
Why?
| | Phosphoprotein Phosphatases | 1 | 1996 | 67 | 0.040 |
Why?
| | Point Mutation | 1 | 1997 | 227 | 0.040 |
Why?
| | Echocardiography | 1 | 2018 | 556 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 1999 | 360 | 0.030 |
Why?
| | Prostatic Neoplasms | 1 | 2002 | 938 | 0.030 |
Why?
| | Crosses, Genetic | 2 | 2008 | 138 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1376 | 0.030 |
Why?
| | Microscopy, Fluorescence | 3 | 2000 | 409 | 0.030 |
Why?
| | Clathrin-Coated Vesicles | 1 | 2013 | 3 | 0.030 |
Why?
| | Sperm Motility | 2 | 2004 | 28 | 0.030 |
Why?
| | Syntaxin 1 | 1 | 2013 | 14 | 0.030 |
Why?
| | Clathrin | 1 | 2013 | 27 | 0.030 |
Why?
| | Tadalafil | 1 | 2013 | 7 | 0.030 |
Why?
| | Chemotactic Factors | 1 | 1993 | 51 | 0.030 |
Why?
| | Dimerization | 2 | 2006 | 181 | 0.030 |
Why?
| | TATA Box | 1 | 1993 | 24 | 0.030 |
Why?
| | Chemokines, CXC | 1 | 1993 | 61 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1996 | 347 | 0.030 |
Why?
| | Survival | 1 | 2013 | 39 | 0.030 |
Why?
| | Biological Transport | 2 | 2005 | 380 | 0.030 |
Why?
| | Growth Substances | 1 | 1993 | 136 | 0.030 |
Why?
| | Aging | 4 | 2008 | 1673 | 0.030 |
Why?
| | Pain | 1 | 2018 | 735 | 0.030 |
Why?
| | Cricetinae | 2 | 2005 | 262 | 0.030 |
Why?
| | In Vitro Techniques | 2 | 2006 | 1083 | 0.030 |
Why?
| | Rats, Wistar | 1 | 1993 | 395 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2013 | 311 | 0.030 |
Why?
| | Anemia | 1 | 1993 | 145 | 0.030 |
Why?
| | Species Specificity | 2 | 2005 | 560 | 0.020 |
Why?
| | Random Amplified Polymorphic DNA Technique | 1 | 2011 | 2 | 0.020 |
Why?
| | Apoptosis | 3 | 2006 | 2453 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2013 | 416 | 0.020 |
Why?
| | Wound Healing | 1 | 2013 | 271 | 0.020 |
Why?
| | Blotting, Southern | 2 | 2001 | 66 | 0.020 |
Why?
| | Protein Structure, Tertiary | 2 | 2005 | 820 | 0.020 |
Why?
| | Organ Specificity | 2 | 2002 | 274 | 0.020 |
Why?
| | Cell Fractionation | 2 | 2000 | 53 | 0.020 |
Why?
| | Gestational Age | 1 | 1993 | 765 | 0.020 |
Why?
| | Cell Cycle | 2 | 2005 | 546 | 0.020 |
Why?
| | Mice, Inbred Strains | 2 | 2001 | 404 | 0.020 |
Why?
| | DNA Primers | 2 | 2003 | 532 | 0.020 |
Why?
| | Transcriptional Activation | 2 | 2005 | 347 | 0.020 |
Why?
| | Mice, Inbred BALB C | 2 | 2003 | 1198 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2011 | 626 | 0.020 |
Why?
| | Heterozygote | 1 | 2008 | 258 | 0.020 |
Why?
| | Neutrophils | 1 | 1993 | 1136 | 0.020 |
Why?
| | Animals, Newborn | 2 | 2003 | 803 | 0.020 |
Why?
| | Cell Movement | 2 | 2004 | 887 | 0.020 |
Why?
| | Fertility | 1 | 2008 | 134 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 460 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2001 | 403 | 0.020 |
Why?
| | Time Factors | 3 | 2004 | 6362 | 0.020 |
Why?
| | Protein Binding | 2 | 2005 | 1965 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3160 | 0.020 |
Why?
| | Rats, Inbred F344 | 2 | 1998 | 245 | 0.020 |
Why?
| | Models, Genetic | 2 | 2000 | 589 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 459 | 0.020 |
Why?
| | Histone Chaperones | 1 | 2006 | 14 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2006 | 412 | 0.020 |
Why?
| | Cycloheximide | 1 | 2005 | 55 | 0.020 |
Why?
| | Bone Marrow | 2 | 1997 | 250 | 0.020 |
Why?
| | Leucine Zippers | 1 | 2005 | 16 | 0.020 |
Why?
| | Neurospora crassa | 1 | 2005 | 16 | 0.020 |
Why?
| | Hydroxyurea | 1 | 2005 | 30 | 0.020 |
Why?
| | Gene Components | 1 | 2005 | 5 | 0.020 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2005 | 19 | 0.020 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2005 | 37 | 0.020 |
Why?
| | Cricetulus | 1 | 2005 | 98 | 0.020 |
Why?
| | Half-Life | 1 | 2005 | 147 | 0.020 |
Why?
| | Caspases | 1 | 2006 | 263 | 0.020 |
Why?
| | Metribolone | 1 | 2005 | 5 | 0.020 |
Why?
| | Child, Preschool | 1 | 2019 | 9442 | 0.020 |
Why?
| | Histidine | 1 | 2005 | 63 | 0.020 |
Why?
| | Nuclear Pore Complex Proteins | 1 | 2005 | 34 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 75 | 0.020 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2005 | 21 | 0.020 |
Why?
| | Glycosylation | 1 | 2005 | 129 | 0.020 |
Why?
| | Adherens Junctions | 1 | 2005 | 26 | 0.020 |
Why?
| | Flagella | 1 | 2004 | 19 | 0.020 |
Why?
| | Sperm-Ovum Interactions | 1 | 2004 | 12 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2005 | 161 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2005 | 169 | 0.020 |
Why?
| | Mitochondria | 2 | 2003 | 785 | 0.020 |
Why?
| | Fertilization | 1 | 2004 | 43 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2005 | 334 | 0.020 |
Why?
| | Receptors, Odorant | 1 | 2004 | 36 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2005 | 147 | 0.020 |
Why?
| | Chemotaxis | 1 | 2004 | 135 | 0.010 |
Why?
| | DNA Replication | 1 | 2005 | 210 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2005 | 302 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2004 | 240 | 0.010 |
Why?
| | Transcription Initiation Site | 1 | 2003 | 42 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2013 | 3670 | 0.010 |
Why?
| | Ornithine Carbamoyltransferase | 1 | 2003 | 2 | 0.010 |
Why?
| | Protamines | 1 | 2003 | 5 | 0.010 |
Why?
| | Models, Chemical | 1 | 2004 | 267 | 0.010 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 353 | 0.010 |
Why?
| | HSP47 Heat-Shock Proteins | 1 | 2002 | 4 | 0.010 |
Why?
| | Seminal Plasma Proteins | 1 | 2002 | 10 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 2005 | 407 | 0.010 |
Why?
| | Restriction Mapping | 1 | 2002 | 75 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2003 | 242 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 2005 | 380 | 0.010 |
Why?
| | Genome | 1 | 2005 | 271 | 0.010 |
Why?
| | Base Pairing | 1 | 2002 | 59 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 2002 | 82 | 0.010 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2002 | 16 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2003 | 146 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 219 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 2003 | 151 | 0.010 |
Why?
| | Isoenzymes | 1 | 2003 | 296 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 2002 | 76 | 0.010 |
Why?
| | COS Cells | 1 | 2002 | 184 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2006 | 563 | 0.010 |
Why?
| | PTEN Phosphohydrolase | 1 | 2003 | 143 | 0.010 |
Why?
| | Flutamide | 1 | 2001 | 5 | 0.010 |
Why?
| | Prostatic Hyperplasia | 1 | 2002 | 38 | 0.010 |
Why?
| | Androgen Receptor Antagonists | 1 | 2001 | 30 | 0.010 |
Why?
| | Dipeptides | 1 | 2001 | 51 | 0.010 |
Why?
| | Mice, Nude | 1 | 2003 | 655 | 0.010 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2000 | 9 | 0.010 |
Why?
| | Escherichia coli | 1 | 2005 | 756 | 0.010 |
Why?
| | Pregnancy | 1 | 1993 | 5667 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2000 | 94 | 0.010 |
Why?
| | Androgen Antagonists | 1 | 2001 | 70 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2008 | 2822 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1617 | 0.010 |
Why?
| | Signal Transduction | 2 | 2005 | 4677 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2000 | 153 | 0.010 |
Why?
| | Luteinizing Hormone | 1 | 2001 | 173 | 0.010 |
Why?
| | Stromal Cells | 1 | 2001 | 100 | 0.010 |
Why?
| | Pancreas | 1 | 2003 | 279 | 0.010 |
Why?
| | Sequence Homology | 1 | 2000 | 40 | 0.010 |
Why?
| | Ornithine Decarboxylase Inhibitors | 1 | 2000 | 7 | 0.010 |
Why?
| | Phospholipid Transfer Proteins | 1 | 2000 | 11 | 0.010 |
Why?
| | Basement Membrane | 1 | 2000 | 32 | 0.010 |
Why?
| | Ornithine Decarboxylase | 1 | 2000 | 12 | 0.010 |
Why?
| | Frameshifting, Ribosomal | 1 | 2000 | 5 | 0.010 |
Why?
| | Mutation | 2 | 2002 | 3426 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 18342 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 1928 | 0.010 |
Why?
| | Polyamines | 1 | 2000 | 39 | 0.010 |
Why?
| | CHO Cells | 1 | 2000 | 143 | 0.010 |
Why?
| | Child | 1 | 2019 | 19029 | 0.010 |
Why?
| | CapZ Actin Capping Protein | 1 | 1999 | 2 | 0.010 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2001 | 193 | 0.010 |
Why?
| | Gonads | 1 | 1999 | 29 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2000 | 117 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 353 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2003 | 688 | 0.010 |
Why?
| | Inbreeding | 1 | 1999 | 16 | 0.010 |
Why?
| | CpG Islands | 1 | 1999 | 119 | 0.010 |
Why?
| | Stem Cell Transplantation | 1 | 2000 | 151 | 0.010 |
Why?
| | Calcium | 1 | 2004 | 1148 | 0.010 |
Why?
| | Selenoprotein P | 1 | 1998 | 3 | 0.010 |
Why?
| | Mesylates | 1 | 1998 | 8 | 0.010 |
Why?
| | Fibroblasts | 1 | 2003 | 836 | 0.010 |
Why?
| | Selenoproteins | 1 | 1998 | 8 | 0.010 |
Why?
| | Rabbits | 1 | 1999 | 778 | 0.010 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1997 | 9 | 0.010 |
Why?
| | Receptors, LH | 1 | 1997 | 8 | 0.010 |
Why?
| | Cathepsin L | 1 | 1997 | 9 | 0.010 |
Why?
| | Clusterin | 1 | 1997 | 10 | 0.010 |
Why?
| | Cathepsins | 1 | 1997 | 22 | 0.010 |
Why?
| | Kidney | 1 | 2005 | 1351 | 0.010 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2000 | 312 | 0.010 |
Why?
| | Drosophila melanogaster | 1 | 1999 | 200 | 0.010 |
Why?
| | Erythroid Precursor Cells | 1 | 1997 | 4 | 0.010 |
Why?
| | Yolk Sac | 1 | 1997 | 5 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 1997 | 61 | 0.010 |
Why?
| | Aspartic Acid | 1 | 1997 | 85 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1997 | 94 | 0.010 |
Why?
| | Valine | 1 | 1997 | 76 | 0.010 |
Why?
| | Protein Phosphatase 2C | 1 | 1996 | 14 | 0.010 |
Why?
| | Protein Phosphatase 2 | 1 | 1996 | 35 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 2916 | 0.010 |
Why?
| | Genetic Markers | 1 | 1997 | 338 | 0.010 |
Why?
| | Conserved Sequence | 1 | 1997 | 219 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 723 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1996 | 368 | 0.010 |
Why?
| | Glycoproteins | 1 | 1997 | 317 | 0.010 |
Why?
| | Models, Biological | 1 | 2002 | 1698 | 0.010 |
Why?
| | RNA | 1 | 2000 | 829 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1620 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2000 | 949 | 0.010 |
Why?
| | Antioxidants | 1 | 1998 | 562 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 1997 | 1218 | 0.010 |
Why?
| | Chemokine CXCL1 | 1 | 1993 | 67 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1997 | 2855 | 0.010 |
Why?
| | Aged | 1 | 2002 | 19557 | 0.000 |
Why?
| | Middle Aged | 1 | 2002 | 27434 | 0.000 |
Why?
|
|
Yomogida's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|